CAM
CORV

ClariVest Asset Management’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

ClariVest Asset Management’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-21,187
Closed -$109K – 766
2016
Q2 		$109K Buy
+21,187
New +$102K ﹤0.01% 516

Other funds holding CORV

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.23B AUM 51.32% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIS
AlphaOne Investment Services West Chester, Pennsylvania $79.5M AUM 49.42% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ClariVest Asset Management's CORV Position: Q3 2016 in Review

ClariVest Asset Management sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q3 2016, closing a stake of 21,187 shares — an estimated $109K sold.

ClariVest Asset Management first reported a position in CORV in Q2 2016 and held it in 1 quarter. The position peaked at $109K in Q2 2016. 33 funds tracked by Wall St. Rank hold CORV as of Q3 2016.

  • ClariVest Asset Management reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q3 2016 after selling out during the quarter.
  • ClariVest Asset Management sold 21,187 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q3 2016, an estimated $109K.
  • ClariVest Asset Management first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q2 2016 and held it in 1 quarter.
  • ClariVest Asset Management's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $109K in Q2 2016.
  • 33 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q3 2016.

Based on ClariVest Asset Management's 13F filing for Q3 2016, filed 7 Nov 2016.